CyMedica rebrands knee pain band under direct-to-consumer Motive Health
10 Jul 2023
Drug Approval
Preview
Source: FierceBiotech
Once known as CyMedica’s IntelliHab system, and then later renamed e-vive, the noninvasive Motive Knee uses a smartphone-connected stimulator to help strengthen the quadriceps and take pressure off the joint.
CyMedica Orthopedics is taking its wearable knee pain treatment direct-to-the-consumer, relaunching its offering under the wellness brand Motive Health.
Previously requiring a prescription, the company’s FDA-cleared muscle stimulation device—the newly rechristened Motive Knee—will now be available exclusively on its website, with prices starting at $399.
Once known as CyMedica’s IntelliHab system, and then later renamed e-vive, the noninvasive Motive Knee uses a smartphone-connected brace worn around the knee and employs electrical pulses to help contract and strengthen the quadriceps muscles with the goal of taking painful pressure off the knee joint.
“Knee pain causes people to limit exercise and reduce movement, which leads to weaker quadriceps muscles and less support around the knee joint,” co-founder Struan Coleman said in the company’s announcement.
The company’s at-home approach obtained a 510(k) clearance from the FDA in 2021, for people with knee osteoarthritis, with treatment sessions designed to last about 30 minutes per day.
CyMedica previously approximated that knee osteoarthritis affects about 14 million patients in the U.S.—but now Motive Health intends to reach a larger number of people through its direct e-commerce platform, targeting the one-in-four adults it estimates currently suffer from knee pain.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.